Communiqués KALA BIO, Inc. Deutsche Boerse AG

Actions

27F0

US4831192020

Temps réel estimé Tradegate Autres places de cotation 12:10:29 03/07/2024			Varia. 5j.	Varia. 1 janv.
6,248 ^EUR	-1,06%		+42,86%	-7,04%

27/06	Les plus fortes hausses de la mi-journée	MT
27/06	Mise à jour sectorielle : Les actions du secteur de la santé sont mixtes en pré-marché jeudi	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

KALA BIO Announces $12,500,000 Private Placement	27/06	AQ
KALA BIO : Corporate Overview - June 2024	05/06	PU
KALA BIO to Present at Jefferies Global Healthcare Conference	29/05	AQ
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	14/05	AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04	AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/03	AQ
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26/02	AQ
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02	AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01	AQ
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	13/11	AQ
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	21/09/23	AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20/09/23	AQ
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	05/09/23	AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	07/08/23	AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	04/08/23	AQ
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K	02/08/23	PU
KALA BIO to Participate in Upcoming Investor Conferences in August	02/08/23	AQ
Kala Pharmaceuticals Announces Name Change to KALA BIO	02/08/23	AQ
Kala Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	20/07/23	AQ
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/07/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués KALA BIO, Inc. Deutsche Boerse AG

Actions

27F0

US4831192020

Communiqués

Filtres